TipRanks
Go Ultimate55% OFF

Patel Samir Rashmikant Insider Profile

4 Followers

Patel Samir Rashmikant, Director at Akari Therapeutics, holds 12.10K shares in Akari Therapeutics (Ticker: AKTX), holds ― shares in CytoDyn (Ticker: CYDY).

Patel Samir Rashmikant's Trading History

AKTX
Akari Therapeutics
Oct 16, 2026DirectorUninformative Buy49.71K$99.72K
CYDY
CytoDyn
―Director――

You May Also Like

Patel Samir Rashmikant insider profile FAQ

What stocks does Patel Samir Rashmikant hold?
Patel Samir Rashmikant holds: AKTX, CYDY stocks.
What was Patel Samir Rashmikant’s latest transaction?
Patel Samir Rashmikant’s latest transaction was an Uninformative Buy of $49.71K.
What is Patel Samir Rashmikant's role in Akari Therapeutics?
Patel Samir Rashmikant's role in Akari Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.